Discovery of Novel Gene Mutations in Leukemia Patients Opens Up Personalized Therapy Options, Ludwig-Maximilians-University and Helmholtz Zentrum Munchen Study

Published: Aug 05, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Specific mutations (N676K) in the FLT3 receptor can contribute to the development of acute myeloid leukemia. The FLT3 receptor regulates cell growth, while activating gene mutations promote the uncontrolled proliferation of white blood cells. These findings were reported in the specialist journal Blood by a group of scientists from the Helmholtz Zentrum M√ľnchen and the Hospital of the Ludwig Maximilians University (LMU) in Munich as part of a clinical research collaboration with the German Cancer Consortium (DKTK).

Hey, check out all the research scientist jobs. Post your resume today!

Back to news